Bimekizumab safety and tolerability in patients with moderate to severe plaque psoriasis: Analysis of pooled data from up to three years of treatment in five phase 3/3b clinical trials
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2023）
摘要
Introduction: Psoriasis is a chronic condition requiring long-term management; evaluating long-term safety of treatments is important.
更多查看译文
关键词
severe plaque psoriasis,bimekizumab safety,clinical trials
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要